Cancer Research Experiences for Undergraduates (CREU)
Cancer Research Experiences for Undergraduates (CREU)
批准号:
10460905
负责人:
MARY ELAINE REYLAND
金额:
$32.4万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-09-01 至 2025-08-31
关键词:
AddressAdmission activityAreaBioinformaticsBiomedical ResearchBiotechnologyCancer BiologyClinicClinicalClinical OncologyColoradoCoupledDevelopmentEducational workshopEnrollmentEvaluationEventExposure toFacultyFutureGoalsImmersionInstitutionInvestigational TherapiesLaboratoriesLearningLinkMalignant NeoplasmsMeasuresMentorsMinority RecruitmentMinority-Serving InstitutionNew MexicoPostdoctoral FellowRecording of previous eventsRecruitment ActivityResearchResearch TechnicsScienceScientistStructureStudentsThe University of Colorado Cancer CenterTrainingTranslatingUnderrepresented MinorityUniversitiesanticancer researchbasecareerdesignexperienceinnovative technologiesinterestlaboratory experiencemeetingsmolecular diagnosticspersonalized medicinepre-doctoralprogramsrecruitsuccesssummer researchtooltraining opportunitytranslational cancer researchtranslational potentialundergraduate research experienceundergraduate studentuniversity student
中文摘要
摘要
科罗拉多大学安舒茨分校(CU Anschutz)在培养本科生、预科学生和
以及生物医学科学的博士后科学家,特别是在癌症研究方面。最重要的是
本科生癌症研究体验(CREU)计划的目标是提供一种机制
通过它,本科生可以探索癌症研究作为未来的职业。在这项研究中-
密集的体验,学生将在实验室里花10周的时间与来自
科罗拉多大学癌症中心。学生将从52名具有以下专业知识的合格导师中进行选择
基础和临床/转化性癌症研究。CREU主要是一种研究密集型体验,
然而,学生们也将参加每周一次的研讨会,探讨癌症生物学的基本问题。
和职业发展,包括职业指导。此外,学生们将从各种各样的课程中进行选择
根据他们的兴趣,组织临床/转化性研讨会(CTW)。CTW通常为半天
与加州大学安舒茨分校的教职员工和生物技术公司合作的经验,并将
旨在利用我们校园的独特优势和癌症培训机会
个性化医学和生物信息学、癌症病理生物学和分子诊断学,以及
实验治疗学和生物技术。共有26名学生将被选中参加
从一批国家申请者中选出CREU。为了确保不同学员的代表性,我们有
与两个为少数族裔服务的机构--檀香山夏米纳德大学和
新墨西哥大学。来自这些院校的申请者将被优先考虑
参加CREU,只要他们符合我们的招生标准。我们也会积极招聘以下人员-
代表学生参加地区和全国少数民族招生活动。CREU计划是
旨在为有兴趣的大学生提供潜在的变革性体验
从事生物医学研究,但在癌症研究方面的身临其境经验有限。
我们的目标是增加学生的数量,特别是来自代表不足的少数族裔的学生,他们
选择从事癌症研究作为职业。我们将使用以下工具来确定我们实现目标的程度
短期和长期评价工具。
英文摘要
Summary
The University of Colorado Anschutz (CU Anschutz) has a strong history of training undergraduate, pre-
and post-doc scientists in the biomedical sciences, and specifically in cancer research. The overarching
goal of the Cancer Research Experience for Undergraduates (CREU) program is to provide a mechanism
through which undergraduate students can explore cancer research as a future career. In this research-
intensive experience, students will spend 10 weeks in a laboratory working with a mentor from the
University of Colorado Cancer Center. Students will choose from 52 qualified mentors with expertise in
basic and clinical/ translational cancer research. CREU is primarily a research-intensive experience,
however students will also attend weekly seminars that explore fundamental questions in cancer biology
and professional development, including career mentoring. In addition, students will select from a variety
of clinical/translational workshops (CTWs) based on their interests. CTW's will typically be ½ day
experiences with faculty and biotechnology companies on the CU Anschutz campus and will be
structured so as to capitalize on unique strengths and cancer training opportunities on our campus in
personalized medicine and bioinformatics, cancer pathobiology and molecular diagnostics, and
experimental therapeutics and biotechnology. A total of 26 students will be selected to participate in
CREU from a pool of national applicants. To assure representation of diverse trainees, we have
established “links” to two minority serving institutions, Chaminade University of Honolulu and the
University of New Mexico. Applicants from these institutions will be given preferential consideration for
participation in CREU, provided they meet our admissions standards. We will also actively recruit under-
represented students at regional and national minority recruitment events. The CREU program is
designed to provide potentially transformative experiences for college students who are interested in
careers in biomedical research, but who have had limited immersive experiences in cancer research.
Our goal is to increase the number of students, particularly from underrepresented minorities, who
choose to pursue cancer research for a career. We will determine how well we meet our goals using
short and long-term evaluation tools.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Colorado HNC SPORE Developmental Research Program
-
批准号:10477468
-
项目类别:
-
资助金额:$9.56万
-
财政年份:2021
-
负责人:MARY ELAINE REYLAND
-
依托单位:
Colorado HNC SPORE Developmental Research Program
-
批准号:10704605
-
项目类别:
-
资助金额:$9.56万
-
财政年份:2021
-
负责人:MARY ELAINE REYLAND
-
依托单位:
Colorado HNC SPORE Developmental Research Program
-
批准号:10268848
-
项目类别:
-
资助金额:$10.28万
-
财政年份:2021
-
负责人:MARY ELAINE REYLAND
-
依托单位:
Cancer Research Experiences for Undergraduates (CREU)
-
批准号:9792114
-
项目类别:
-
资助金额:$32.4万
-
财政年份:2019
-
负责人:MARY ELAINE REYLAND
-
依托单位:
Cancer Research Experiences for Undergraduates (CREU)
-
批准号:10670888
-
项目类别:
-
资助金额:$29.2万
-
财政年份:2019
-
负责人:MARY ELAINE REYLAND
-
依托单位:
Cancer Research Experiences for Undergraduates (CREU)
-
批准号:9980322
-
项目类别:
-
资助金额:$32.4万
-
财政年份:2019
-
负责人:MARY ELAINE REYLAND
-
依托单位:
PKCdelta and chromatin remodeling
-
批准号:9903645
-
项目类别:
-
资助金额:$21.74万
-
财政年份:2018
-
负责人:MARY ELAINE REYLAND
-
依托单位:
PKCdelta and salivary gland radioprotection
-
批准号:10190894
-
项目类别:
-
资助金额:$48.19万
-
财政年份:2018
-
负责人:MARY ELAINE REYLAND
-
依托单位:
PKCdelta and salivary gland radioprotection
-
批准号:10402350
-
项目类别:
-
资助金额:$47.71万
-
财政年份:2018
-
负责人:MARY ELAINE REYLAND
-
依托单位:
Radio-protection of the salivary gland
-
批准号:8684939
-
项目类别:
-
资助金额:$19.38万
-
财政年份:2014
-
负责人:MARY ELAINE REYLAND
-
依托单位:
FASEB SRC on Lipids and Lipid Regulated Kinases in Cancer
-
批准号:8782705
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2014
-
负责人:MARY ELAINE REYLAND
-
依托单位:
2011 Salivary Glands and Exocrine Biology Gordon Research Conference
-
批准号:8059865
-
项目类别:
-
资助金额:$3.0万
-
财政年份:2011
-
负责人:MARY ELAINE REYLAND
-
依托单位:
PKCdelta and Salivary Gland Apoptosis
-
批准号:7932536
-
项目类别:
-
资助金额:$20.19万
-
财政年份:2009
-
负责人:MARY ELAINE REYLAND
-
依托单位:
2009 Salivary Glands and Exocrine Secretion Gordon Research Conference
-
批准号:7665657
-
项目类别:
-
资助金额:$3.0万
-
财政年份:2009
-
负责人:MARY ELAINE REYLAND
-
依托单位:
ROLE OF PKC IN CELL TURNOVER IN THE MAMMARY GLAND
-
批准号:7018039
-
项目类别:
-
资助金额:$16.05万
-
财政年份:2005
-
负责人:MARY ELAINE REYLAND
-
依托单位:
PKC regulation of salivary acinar cell apoptosis
-
批准号:6847153
-
项目类别:
-
资助金额:$11.68万
-
财政年份:2004
-
负责人:MARY ELAINE REYLAND
-
依托单位:
Regulation of Salivary Cell Apoptosis by PKC
-
批准号:6712569
-
项目类别:
-
资助金额:$34.52万
-
财政年份:2003
-
负责人:MARY ELAINE REYLAND
-
依托单位:
PKCdelta and Salivary Gland Apoptosis
-
批准号:7888270
-
项目类别:
-
资助金额:$35.68万
-
财政年份:2003
-
负责人:MARY ELAINE REYLAND
-
依托单位:
PKCdelta and Salivary Gland Apoptosis
-
批准号:7667149
-
项目类别:
-
资助金额:$36.15万
-
财政年份:2003
-
负责人:MARY ELAINE REYLAND
-
依托单位:
PKCdelta and Salivary Gland Apoptosis
-
批准号:8110474
-
项目类别:
-
资助金额:$34.6万
-
财政年份:2003
-
负责人:MARY ELAINE REYLAND
-
依托单位: